The CDC has released a report detailing their concerns about the increase in cases of antibiotic-resistant Shigella and provided recommendations for clinicians who believe they have identified such a case.
...
It is well-known that tuberculosis is associated with an increased risk for cardiovascular disease. However, the researchers investigated whether latent tuberculosis infection is linked with acute...
The FDA has expanded the indication for a drug formerly approved for the treatment of patients with complicated intra-abdominal infections and complicated urinary tract infections.
New guidelines from the Society of Healthcare Epidemiology of America address protocols for preventing the spread of infections including Clostridium difficile, MRSA, and more.
Accurately distinguishing bacterial infections from viral ones can be difficult, often leading to antibiotic misuse. In a new study, researchers tested the accuracy of a novel assay in distinguishing...
The lipoglycopeptide dalbavancin, known for its efficacy against pathogens that cause acute bacterial skin and skin structure infections (ABSSSI), has been approved by the FDA as a single- or 2-dose...
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
